Public & Societal Benefit
(W99)
990 on File
CONVERGENT IMPACT INC
Financial strength (30%)
92/100
Reliability (20%)
40/100
Effectiveness (25%)
71/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$1.8M
Total Revenue
$71K
Total Expenses
$1.8M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
81.1%
Fundraising Efficiency
N/A
Operating Reserve
302.47x
Liability-to-Asset
0.3%
Revenue Diversification
97.3%
Executive Compensation
$0
Compared with Peers
FY 2023
Compared with 2,844 similar organizations
(United States, Public & Societal Benefit, under $100K in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
81.1% | 80.7% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
18.9% | 8.6% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
302.5 mo | 17.0 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
97.3% | 100.0% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
795.4% | -1.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-63.0% | 2.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
96.2% | 13.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $1.8M | $71K | $1.8M | 81.1% | 0 |
| 2022 | $206K | $192K | $14K | 98.6% | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.